Quarter Ended 31 March, 2020 Page 1 Executive Summary Unit : Million baht 2020 2019 Total revenues * 4,506.78 4,014.33 492.45 12.3 Total cost and expenses * 2,522.92 2,311.10 211.82 9.2 Gain (Loss) on
compared to total revenue from medical treatment in the 1st quarter of Year 2020 equaled to 79.0%, and in the 1st quarter of Year 2019 equaled to 80.2%. A decrease of nearly 1.2% in the cost of medical
decreased total sales revenue of Baht 164.19 million or 14.41% compared to the same period last year, resulting in lower gross profit of Baht 26.76 million or 7.56% compared to the same period last year. 3
million baht or 83.76 percent. The significant accounting transactions changed as follows; 1) Total revenues from consolidated financial statements, decreased from 84.58 million baht to 36.03 million baht
a normal business support transaction for the company In this regard, With a value compared to last year's sales of not more than 49,000,000 baht and the total value not more than 3 % of the Net
period. Financial Position At the end of 2019 and the first 3 months of 2020, the Company and its subsidiary had the total assets of 443.14 THB mn and 570.13 THB mn respectively. Most of the current assets
(125.82) (43.40) Sale of food and beverages 53.97 96.09 (42.12) (43.83) Other revenue from operations 39.25 72.84 (33.59) (46.11) Total revenues 257.28 458.81 (201.53) (43.92) Other income Other income for
40.63 million baht which is equivalent to 0.04 baht per share for the third quarter of 2019, compared to a net profit of 29.90 million baht for the same period in the previous year, representing a total
/ (decrease) %change Revenues from sales and Service income 217.59 157.19 60.40 38.42% Other revenues 2.37 0.18 2.19 1,216.67% Total revenues 219.96 157.37 62.59 39.77% Cost of sales and Service income 109.51
previous year. 3. Selling and Administrative Expenses For the third quarter of year 2019, the Company’s SG&A expenses was USD 35.75 million (or equivalent to Baht 1,096.82 million), or 4.20% of the total